Aerovate Therapeutics
(NASDAQ:AVTE)
$25.75
-0.04[-0.16%]
Last update: 1:48PM
Day High/Low25.22 - 26.66
52 Week High/Low7.74 - 27.83
Open / Close25.22 / -
Float / Outstanding9.7M / 24.4M
Vol / Avg.7.5K / 100.6K
Mkt Cap628.6M
P/E-
50d Avg. Price17.21
Div / Yield-
Payout Ratio-
EPS-0.34
Total Float9.7M

Aerovate Therapeutics (NASDAQ:AVTE), Quotes and News Summary

Aerovate Therapeutics (NASDAQ: AVTE)

Day High/Low25.22 - 26.66
52 Week High/Low7.74 - 27.83
Open / Close25.22 / -
Float / Outstanding9.7M / 24.4M
Vol / Avg.7.5K / 100.6K
Mkt Cap628.6M
P/E-
50d Avg. Price17.21
Div / Yield-
Payout Ratio-
EPS-0.34
Total Float9.7M
Sector: Health Care.Industry: Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-14
REV
Q2 2022Est.ActualSurprise
EPS-0.450-0.490 -0.0400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aerovate Therapeutics Questions & Answers

Q
How do I buy Aerovate Therapeutics (AVTE) stock?
A

You can purchase shares of Aerovate Therapeutics (NASDAQ: AVTE) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Aerovate Therapeutics's (AVTE) competitors?
Q
What is the target price for Aerovate Therapeutics (AVTE) stock?
A

The latest price target for Aerovate Therapeutics (NASDAQ: AVTE) was reported by BTIG on Friday, February 11, 2022. The analyst firm set a price target for 24.00 expecting AVTE to fall to within 12 months (a possible -6.80% downside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Aerovate Therapeutics (AVTE)?
A

The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $25.75 last updated Today at August 15, 2022, 5:48 PM UTC.

Q
Does Aerovate Therapeutics (AVTE) pay a dividend?
A

There are no upcoming dividends for Aerovate Therapeutics.

Q
When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?
A

Aerovate Therapeutics’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q
Is Aerovate Therapeutics (AVTE) going to split?
A

There is no upcoming split for Aerovate Therapeutics.

Q
What sector and industry does Aerovate Therapeutics (AVTE) operate in?
A

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.